Next Article in Journal
Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
Previous Article in Journal
Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials
Previous Article in Special Issue
Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
Article

Article Versions Notes

Cancers 2012, 4(2), 566-580; https://doi.org/10.3390/cancers4020566
Action Date Notes Link
article html file updated 23 January 2013 19:56 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 26 January 2013 11:14 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 29 January 2013 04:39 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article xml file uploaded 1 February 2013 09:36 CET Update https://www.mdpi.com/2072-6694/4/2/566/xml
article html file updated 1 February 2013 09:36 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 6 February 2013 08:17 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 7 February 2013 02:48 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 7 February 2013 12:55 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 17 June 2015 00:28 CEST Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 25 March 2019 12:01 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 8 May 2019 17:19 CEST Update https://www.mdpi.com/2072-6694/4/2/566/html
article html file updated 5 February 2020 20:48 CET Update https://www.mdpi.com/2072-6694/4/2/566/html
Back to TopTop